Skip to Main Content

Author Details

Steven M Belknap
Northwestern University Feinberg School of MedicineChicago
1987
53
23
PMIDPaper TitleJournal TitlePublished Year
28508417Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis.Pediatr Dermatol2017
28241296Current vs past use of NSAIDs was linked to increased risk for first HF hospitalization; risk varied by drug.Ann Intern Med2017
28289563Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.PeerJ2017
29255861In adults, benzodiazepines were not linked to increased risk for mortality at 6 mo but were linked at 12 and 48 mo.Ann Intern Med2017
25566825Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) project.Drug Saf2015
26214273Disclosure of Boxed Warnings to Research Participants.JAMA Intern Med2015
25830296Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.JAMA Dermatol2015
25984879ACP Journal Club. Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment.Ann Intern Med2015
24057195Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.Pediatr Radiol2014
25600332Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration's Adverse Event Reporting System Narratives.JMIR Med Inform2014
25230161Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.Br J Radiol2014
25023265In adults, use of anxiolytic or hypnotic drugs was associated with increased risk for mortality.Ann Intern Med2014
23318332ACP Journal Club. NSAIDs were associated with increased risk for mortality, regardless of time since first MI.Ann Intern Med2013
23814519Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.J Oncol Pract2013
24030903Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR) project.J Clin Pharmacol2013
23671544Characteristics and Causes for Non-Accrued Clinical Research (NACR) at an Academic Medical Institution.J Clin Med Res2013
23426763Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.J Bone Joint Surg Am2013
23480866Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.Expert Opin Drug Saf2013
23553448Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.Drug Saf2013
22385784Amiodarone-associated optic neuropathy: a critical review.Am J Med2012
23041981Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin.Semin Thromb Hemost2012
22831822Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function.Acad Radiol2012
21115603Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.Ann Oncol2011
20571489Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugs.Clin Pharmacol Ther2010
20547897ACP Journal Club. Review: Rapid-response teams do not reduce mortality in hospital patients.Ann Intern Med2010
19458059Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.Clin Cancer Res2009
19755360A ward-based pharmacist intervention reduced emergency department visits and drug-related readmissions in elderly patients.Ann Intern Med2009
18388884Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioids.Clin Pharmacol Ther2008
18311868Review: beta-blockers for hypertension increase risk for new-onset diabetes compared with nondiuretic antihypertensive agents.ACP J Club2008
18375703Review: beta-blockers for hypertension increase risk of new onset diabetes.Evid Based Med2008
17296652Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm.Chest2007
17533207Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.Arch Intern Med2007
16386683Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.J Am Coll Cardiol2006
16568459Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.Cancer2006
16099877Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.Blood2005
15870417The Research on Adverse Drug Events and Reports (RADAR) project.JAMA2005
14722442Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.J Acquir Immune Defic Syndr2004
15459301Pure red-cell aplasia and epoetin therapy.N Engl J Med2004
14551305Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.J Clin Oncol2003
11867978Adverse drug events in emergency department patients.Ann Emerg Med2002
11874278Review: studies on the cardiovascular effects of selective COX-2 inhibitors show mixed results.ACP J Club2002
11061519Relation of plasma oxytocin and prolactin concentrations to milk production in mothers of preterm infants: influence of stress.J Clin Endocrinol Metab2000
11079285Pharmaceutical care of postoperative nausea and vomiting: balanced scorecard for outcomes.Pharmacotherapy2000
9806037A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.J Infect Dis1998
8301196Ascitic fluid albumin and water flows in patients with alcoholic cirrhosis: effects of peritoneovenous shunting.J Lab Clin Med1994
1926282Particle concentration fluorescence immunoassay of gentamicin.Ther Drug Monit1991
3390996Acute tolerance to cocaine in humans.Clin Pharmacol Ther1988
3244269Urinary excretion of cocaine, benzoylecgonine, and ecgonine methyl ester in humans.J Anal Toxicol1988
2439251Effect kinetics of N-acetylprocainamide-induced QT interval prolongation.Clin Pharmacol Ther1987
3597709Pharmacokinetic studies of highly purified human prolactin in normal human subjects.J Clin Endocrinol Metab1987
  • 1 - 50 of 53

Recommended Authors

Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 0
David Geffen School of Medicine, university of california los angeles
Career Start Year 2010
Number of shared co-authors 0
University of Toronto
Career Start Year 2007
Number of shared co-authors 0
Department of Pharmacy, Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 0
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Career Start Year 2005
Number of shared co-authors 0
Brigham and Women's Hospital
Career Start Year 2003
Number of shared co-authors 0
NYU Langone Hospital - Brooklyn Brooklyn
Career Start Year 2001
Number of shared co-authors 0
Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh
Career Start Year 2000
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Center for Primary and Community Care, University of Lucerne
Career Start Year 1998
Number of shared co-authors 0
Western University
Career Start Year 1996
Number of shared co-authors 0
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 0
University of Florida
Career Start Year 1995
Number of shared co-authors 0
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 0
University Health Network
Career Start Year 1994
Number of shared co-authors 1
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1991
Number of shared co-authors 0
Columbia University.
Career Start Year 1990
Number of shared co-authors 0
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 0
university of massachusetts amherst Chan Medical School
Career Start Year 1988
Number of shared co-authors 1
Rutgers University School of Public Health
Career Start Year 1988
Number of shared co-authors 1
Department of Pharmacotherapy, University of Utah Health
Career Start Year 1986
Number of shared co-authors 0
Institute of Health Policy, University of Toronto
Career Start Year 1984
Number of shared co-authors 0
6 Department of Medical Informatics and Clinical Epidemiology.
Career Start Year 1981
Number of shared co-authors 0
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
Mass General Hospital
Career Start Year 1977
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 1975
Number of shared co-authors 0
University of Wisconsin
Career Start Year 1971
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Feinberg School of Medicine, Northwestern University
Co-authored papers 20
Feinberg School of Medicine, Northwestern University
Co-authored papers 15
The University of New Mexico
Co-authored papers 15
Central Texas Veterans Healthcare System
Co-authored papers 11
University of South Carolina
Co-authored papers 11
University of South Carolina College of Pharmacy
Co-authored papers 11
Northwestern Memorial Hospital
Co-authored papers 9
548377Rush University Medical Center
Co-authored papers 6
Feinberg School of Medicine, Northwestern University
Co-authored papers 6
Memorial Sloan-Kettering Cancer Center
Co-authored papers 6
Rutgers Robert Wood Johnson Medical School
Co-authored papers 5
Northwestern University Feinberg School of Medicine
Co-authored papers 4
University of Utah
Co-authored papers 4
Co-authored papers 3
Tulane University School of Medicine
Co-authored papers 3
Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System
Co-authored papers 2
Department of Medical Informatics and Clinical Epidemiology
Co-authored papers 2
University of Texas Southwestern Medical Center
Co-authored papers 2
Co-authored papers 2
Medical University of South Carolina
Co-authored papers 2
Northwestern University, Feinberg School of Medicine
Co-authored papers 1
McMaster University.
Co-authored papers 1
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Co-authored papers 1
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
University of Utah
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
37345National Center for Health Statistics
Co-authored papers 1
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1